share_log

藥明康德：(1)建議變更本公司的註冊資本； 及 (2)建議修訂《公司章程》

WUXI APPTEC: (1) PROPOSED CHANGE OF REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

Hong Kong Stock Exchange ·  Apr 29 21:07
Summary by Futu AI
药明康德（股份代號：2359）於2024年4月29日宣布，董事會在第三屆董事會第十一次會議上議決及批准變更公司註冊資本及修訂公司章程。此次變更將公司註冊資本從人民幣2,962,088,310元調整為人民幣2,933,336,997元。此外，公司已於2023年3月23日及4月3日發行轉換自300百萬美元零息可轉換債券的5,215,825股H股，並於2023年10月25日完成回購註銷部分2019年A股股權激勵計劃的限制性A股股票。2024年1月18日，公司亦完成註銷直接向計劃受託人回購的15,467,500股H股，並於2024年3月20日註銷回購的20,275,407股A股。修訂後的公司章程及註冊資本變更需待2023年股東週年大會通過特別決議案批准後方可實施。公司將適時向股東寄發相關通函。
药明康德（股份代號：2359）於2024年4月29日宣布，董事會在第三屆董事會第十一次會議上議決及批准變更公司註冊資本及修訂公司章程。此次變更將公司註冊資本從人民幣2,962,088,310元調整為人民幣2,933,336,997元。此外，公司已於2023年3月23日及4月3日發行轉換自300百萬美元零息可轉換債券的5,215,825股H股，並於2023年10月25日完成回購註銷部分2019年A股股權激勵計劃的限制性A股股票。2024年1月18日，公司亦完成註銷直接向計劃受託人回購的15,467,500股H股，並於2024年3月20日註銷回購的20,275,407股A股。修訂後的公司章程及註冊資本變更需待2023年股東週年大會通過特別決議案批准後方可實施。公司將適時向股東寄發相關通函。
Ming Kand Pharmaceutical (Stock Code: 2359) announced on 29 April 2024 that the Board of Directors at the 11th Meeting of the Third Board of Directors voted and approved the change in the registered capital of the Company and the amendment of the Articles of Association. The change adjusted the registered capital of the company from RMB2,962,088,310 to RMB2,933,336,997. In addition, the Company issued 5,215,825 shares of H shares on March 23 and April 3, 2023, converted from US$300 million zero-yield convertible notes, and completed the repurchase of a portion of the 2019 A-share share incentive plan on October 25, 2023. On January 18, 2024, the Company also completed the write-down of 15,467,500 shares of H shares repurchased directly to the plan trustee and the repurchase of 20,275,407 shares of Class A shares repurchased on March 20, 2024. The amended Articles of Association and the changes to the registered capital are subject to the approval of a special resolution at the 2023 Annual General Meeting. The Company will send relevant circulars to shareholders in due course.
Ming Kand Pharmaceutical (Stock Code: 2359) announced on 29 April 2024 that the Board of Directors at the 11th Meeting of the Third Board of Directors voted and approved the change in the registered capital of the Company and the amendment of the Articles of Association. The change adjusted the registered capital of the company from RMB2,962,088,310 to RMB2,933,336,997. In addition, the Company issued 5,215,825 shares of H shares on March 23 and April 3, 2023, converted from US$300 million zero-yield convertible notes, and completed the repurchase of a portion of the 2019 A-share share incentive plan on October 25, 2023. On January 18, 2024, the Company also completed the write-down of 15,467,500 shares of H shares repurchased directly to the plan trustee and the repurchase of 20,275,407 shares of Class A shares repurchased on March 20, 2024. The amended Articles of Association and the changes to the registered capital are subject to the approval of a special resolution at the 2023 Annual General Meeting. The Company will send relevant circulars to shareholders in due course.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.